Review Articles in 2020

Filter By:

Article Type
Year
  • This Review summarizes clinical practice for differentiated thyroid cancer, highlighting advances in therapy, including surgery and the use of radioactive iodine, as well as improved diagnostic tools and prognostic classifications. Different management strategies for patients with low-risk, intermediate-risk and high-risk differentiated thyroid cancer are discussed.

    • Martin Schlumberger
    • Sophie Leboulleux
    Review Article
  • This Review examines the evidence that β-cells are active participants in the dialogue with the immune system during the development of type 1 diabetes mellitus. The authors suggest that therapies targeting β-cell health, vitality and function might prove essential, in combination with immunotherapy, to change the course of events leading to β-cell destruction.

    • Bart O. Roep
    • Sofia Thomaidou
    • Arnaud Zaldumbide
    Review Article
  • Exposure to environmental pollutants such as endocrine-disrupting chemicals (EDCs) during critical periods of development can have long-term reproductive consequences. This Review discusses the cellular and molecular consequences of perinatal exposure EDCs with a focus on the neuroendocrine control of reproduction.

    • David Lopez-Rodriguez
    • Delphine Franssen
    • Anne-Simone Parent
    Review Article
  • The bioactive peptides galanin, spexin and kisspeptin have a common ancestral origin. This Review summarizes the available evidence on the role of these peptides in the regulation of metabolism, pancreatic β-cell function, energy homeostasis, mood and behaviour.

    • Edouard G. Mills
    • Chioma Izzi-Engbeaya
    • Waljit S. Dhillo
    Review Article
  • This Review summarizes current knowledge on non-classic and less common causes of hypopituitarism, such as traumatic brain injury, genetic causes, use of immune checkpoint inhibitors, autoimmune diseases and inflammatory diseases. Furthermore, emerging evidence that posterior pituitary damage can affect oxytocin secretion is highlighted.

    • Flavia Prodam
    • Marina Caputo
    • Gianluca Aimaretti
    Review Article
  • The pathophysiology of coronavirus disease 19 (COVID-19) and diabetes mellitus are interlinked, and diabetes mellitus is associated with severe COVID-19 outcomes. This Review highlights new advances in diabetes mellitus and COVID-19, considering disease mechanisms and clinical management of patients with diabetes mellitus in the ongoing pandemic.

    • Soo Lim
    • Jae Hyun Bae
    • Michael A. Nauck
    Review Article
  • This Review provides insight into sexual dimorphism in adipose tissue distribution and substrate metabolism in adipose tissue, skeletal muscle and liver, as well as the underlying mechanisms. The effects of these sex differences on cardiometabolic health are outlined and the potential for developing sex-specific prevention and treatment strategies is discussed.

    • Gijs H. Goossens
    • Johan W. E. Jocken
    • Ellen E. Blaak
    Review Article
  • This Review highlights the landmark T1DM and T2DM trials that inform the current guidelines for HbA1c targets, which remain contentious. In addition, the Review discusses individualized HbA1c targets, examines the limitations of HbA1c and considers alternatives for monitoring glycaemic control.

    • Klara R. Klein
    • John B. Buse
    Review Article
  • Obesity activates stress-activated protein kinases (SAPKs), such as the p38 and JNK stress kinases, in several tissues, including adipose, liver, skeletal muscle, immune organs and the central nervous system. This Review discusses the role of SAPKs in metabolic control and highlights important discoveries in the field.

    • Ivana Nikolic
    • Magdalena Leiva
    • Guadalupe Sabio
    Review Article
  • This Review summarizes the adaptations to lipid metabolism that occur in skeletal muscle in response to either a high-fat diet or exercise training. In addition, obesity-associated impairments in fatty acid oxidation capacity and the importance of exercise for overcoming lipid metabolic inflexibility in obesity are discussed.

    • Andreas Mæchel Fritzen
    • Anne-Marie Lundsgaard
    • Bente Kiens
    Review Article
  • With immune checkpoint blockade (ICB) technologies increasingly being used in cancer immunotherapy, early data suggest that ICB therapies could be effective in thyroid cancer. This Review discusses our current knowledge of the immune response in thyroid cancers, the latest and ongoing immune-based approaches and the future of immunotherapies in thyroid cancer.

    • Jena D. French
    Review Article
  • Fibroblast growth factor 21 (FGF21) confers considerable pharmacological benefits on a cluster of obesity-related metabolic complications when administered to preclinical models. This Review discusses FGF21 analogues and mimetics and highlights their efficacy in preclinical models and clinical trials. The challenges in developing FGF21-based therapeutics are also considered.

    • Leiluo Geng
    • Karen S. L. Lam
    • Aimin Xu
    Review Article
  • This Review outlines the latest understanding of the pathogenesis of primary aldosteronism. Current treatment options are also discussed, including the potential for targeted therapies.

    • Maria-Christina Zennaro
    • Sheerazed Boulkroun
    • Fabio L. Fernandes-Rosa
    Review Article
  • This Review highlights the evidence from clinical trials that diet-induced weight loss interventions can be used to treat type 2 diabetes mellitus. The composition of the diet and the importance of physical exercise programmes are discussed. Lifestyle interventions for prevention of type 2 diabetes mellitus are also considered.

    • Faidon Magkos
    • Mads F. Hjorth
    • Arne Astrup
    Review Article